Global Bone Growth Stimulators Market Report 2018-2022 - Analysis by Application, Product and End-User - ResearchAndMarkets.com

DUBLIN--()--The "Global Bone Growth Stimulators Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

Global bone growth stimulators market is expected to grow at a CAGR of 5.37% during the period 2018-2022.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The latest trend gaining momentum in the market is the growing adoption of MI and robotic surgeries. Healthcare providers, governments, patients, and other key stakeholders have encouraged the shift from traditional open surgeries, which cause pain and require an extended stay in hospitals, to MI surgeries, which require a short hospital stay. The increased demand for such surgeries is due to the increasing number of complications associated with traditional open surgeries. For instance, conventional open surgeries can cause various post-surgical complications such as pain, blood clots, fatigue, muscle atrophy, and infections. Several research studies have also demonstrated the advantages of MI surgeries over conventional open surgeries.

According to the report, one of the major drivers for this market is the growing demand from emerging markets. Vendors are focusing on expanding their businesses in emerging economies to improve their presence and increase their revenue. The increasing prevalence of orthopedic disorders in emerging economies, the growth of the geriatric population of Asia, the increasing number of surgeries in developing countries such as China and India, and the increasing patient pool of emerging economies are increasing the demand for bone growth stimulators

Further, the report states that one of the major factors hindering the growth of this market is high cost and limited reimbursements. Besides the cost of the bone growth stimulator, the cost of spinal fusion surgeries to repair the vertebrae ranges between $26,000 and $34,000. Spinal fusion surgery also includes associated indirect and direct costs such as admission fees, physician fees, and post-hospital rehabilitation expenses. Hence, the overall cost increases.

Key Vendors

  • Bioventus
  • DJO Global
  • Johnson & Johnson
  • Medtronic
  • Orthofix International
  • Stryker
  • Zimmer Biomet

Key Topics Covered

1. Executive Summary

2. Scope of the Report

3. Research Methodology

4. Market Landscape

5. Market Sizing

6. Five Forces Analysis

7. Segmentation by Application

8. Segmentation by Product

9. Customer Landscape

10. Segmentation by End-User

11. Regional Landscape

12. Decision Framework

13. Drivers and Challenges

14. Market Trends

15. Vendor Landscape

16. Vendor Analysis

For more information about this report visit https://www.researchandmarkets.com/research/wr63st/global_bone?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Orthopedic Devices

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Orthopedic Devices